Related Experiment Video
Updated: Feb 8, 2026

Rat Model of Photochemically-Induced Posterior Ischemic Optic Neuropathy
Published on: November 29, 2015
Food derived respiratory complex I inhibitors modify the effect of Leber hereditary optic neuropathy mutations
Ester López-Gallardo1, Sonia Emperador1, Carmen Hernández-Ainsa2
1Departamento de Bioquímica, Biología Molecular y Celular. Universidad de Zaragoza, Zaragoza, Spain; Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain; Centro de Investigaciones Biomédicas En Red de Enfermedades Raras (CIBERER), Zaragoza, Spain.
Abstract:
Mitochondrial DNA mutations in genes encoding respiratory complex I polypeptides can cause Leber hereditary optic neuropathy. Toxics affecting oxidative phosphorylation system can also cause mitochondrial optic neuropathy. Some complex I inhibitors found in edible plants might differentially interact with these pathologic mutations and modify their penetrance. To analyze this interaction, we have compared the effect of rotenone, capsaicin and rolliniastatin-1 on cybrids harboring the most frequent Leber hereditary optic neuropathy mutations and found that m.3460G > A mutation increases rotenone resistance but capsaicin and rolliniastatin-1 susceptibility. Thus, to explain the pathogenicity of mitochondrial diseases due to mitochondrial DNA mutations, their potential interactions with environment factors will have to be considered.
Insights
Environmental toxins can influence Leber hereditary optic neuropathy (LHON) disease severity. Certain plant compounds may alter the impact of mitochondrial DNA mutations, highlighting the need to consider environmental factors in disease pathogenicity.
Area of Science:
- Biochemistry
- Genetics
- Toxicology
Background:
- Mitochondrial DNA (mtDNA) mutations in complex I genes are a primary cause of Leber hereditary optic neuropathy (LHON).
- Environmental toxins impacting the oxidative phosphorylation system can also induce mitochondrial optic neuropathy.
- Plant-derived complex I inhibitors may interact with pathogenic mtDNA mutations, potentially modifying disease penetrance.
Purpose of the Study:
- To investigate the differential effects of complex I inhibitors (rotenone, capsaicin, rolliniastatin-1) on cybrids with common LHON-associated mtDNA mutations.
- To determine if specific mutations influence susceptibility or resistance to these environmental toxins.
Main Methods:
- Utilized cybrid cell models harboring common Leber hereditary optic neuropathy mutations.
- Exposed cybrids to rotenone, capsaicin, and rolliniastatin-1 to assess their effects on mitochondrial function and cell viability.
- Analyzed the interaction between the m.3460G>A mutation and the tested inhibitors.
Main Results:
- The m.3460G>A mutation conferred increased resistance to rotenone.
- Conversely, the m.3460G>A mutation led to heightened susceptibility to capsaicin and rolliniastatin-1.
- These findings indicate mutation-specific responses to environmental complex I inhibitors.
Conclusions:
- The pathogenicity of mitochondrial diseases, such as LHON, is influenced by interactions between mtDNA mutations and environmental factors.
- Environmental exposures, like specific plant compounds, can modulate the clinical presentation and severity of inherited mitochondrial optic neuropathies.
- A comprehensive understanding of mitochondrial disease mechanisms requires consideration of both genetic predisposition and environmental influences.
Related Concept Videos
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Viral Mutations
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...

